- Home
- CRMD vs IRMD Comparison
CRMD vs IRMD Comparison
Compare CRMD & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- IRMD
- Stock Information
- Founded
- CRMD 2006
- IRMD 1992
- Country
- CRMD United States
- IRMD United States
- Employees
- CRMD N/A
- IRMD N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- IRMD Medical/Dental Instruments
- Sector
- CRMD Health Care
- IRMD Health Care
- Exchange
- CRMD Nasdaq
- IRMD Nasdaq
- Market Cap
- CRMD 877.5M
- IRMD 756.5M
- IPO Year
- CRMD 2010
- IRMD 2014
- Fundamental
- Price
- CRMD $11.64
- IRMD $66.17
- Analyst Decision
- CRMD Strong Buy
- IRMD Strong Buy
- Analyst Count
- CRMD 7
- IRMD 1
- Target Price
- CRMD $17.33
- IRMD $72.00
- AVG Volume (30 Days)
- CRMD 1.8M
- IRMD 45.5K
- Earning Date
- CRMD 08-13-2025
- IRMD 08-01-2025
- Dividend Yield
- CRMD N/A
- IRMD 1.03%
- EPS Growth
- CRMD N/A
- IRMD 11.04
- EPS
- CRMD 0.28
- IRMD 1.61
- Revenue
- CRMD $82,553,827.00
- IRMD $77,635,163.00
- Revenue This Year
- CRMD $278.96
- IRMD $10.62
- Revenue Next Year
- CRMD $45.85
- IRMD $9.69
- P/E Ratio
- CRMD $41.93
- IRMD $41.10
- Revenue Growth
- CRMD N/A
- IRMD 11.73
- 52 Week Low
- CRMD $3.61
- IRMD $42.34
- 52 Week High
- CRMD $17.43
- IRMD $66.50
- Technical
- Relative Strength Index (RSI)
- CRMD 47.40
- IRMD 76.85
- Support Level
- CRMD $11.40
- IRMD $55.11
- Resistance Level
- CRMD $12.02
- IRMD $57.36
- Average True Range (ATR)
- CRMD 0.47
- IRMD 1.83
- MACD
- CRMD 0.10
- IRMD 0.60
- Stochastic Oscillator
- CRMD 68.61
- IRMD 97.15
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.